Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02333396 · ClinicalTrials.gov registry record · NA
Improving Communication in the PICU: The Navigate Study
A NA study of Communication, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 442
- Enrollment target
- 2
- Study locations
NCT02333396: Completed NA study of Communication, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
NCT02333396 is a NA study of Communication that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 442 participants, below the 1,408-participant average among 34 other Communication trials with a reported enrollment target (69% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02333396, a NA study of Communication, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 442 participants
- Enrollment target
- 2
- Study locations
Study Summary
The project seeks to study the use of an navigator-based intervention called "PICU Supports." The study will test the impact of PICU Supports during and after PICU discharge on parent outcomes (satisfaction with decision making, decision regret, anxiety, depression, post-traumatic stress, health-related quality of life, and complicated bereavement) and on parent and healthcare team member assessments of communication and team collaboration.
Primary Outcome
Percentage of "excellent" scores in the decision making domain of the Pediatric Family Satisfaction in the Intensive Care Unit (pFS-ICU) questionnaire; minimum=0, maximum=100, higher score is better outcome
Conditions Studied
Interventions
- OTHER PICU Supports
- OTHER Educational Brochure
Study Locations (2)
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago
- The University of Chicago Medicine Comer Children's Hospital - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 442 participants |
| Start Date | 2015-04-06 |
| Est. Completion | 2017-04-28 |
| Phase | NA |
What the finished NCT02333396 record still lists
NCT02333396 is an interventional study that assigns participants to a tested intervention. The registered 442 participants enrollment target is mid-sized for trials with a published cap, below the 1,408-participant average among 34 other Communication trials with a reported enrollment target (69% lower).
The record links to 1 condition, with Communication appearing as the primary indexed condition, and to 2 interventions - of which PICU Supports is the first listed.
NCT02333396 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT02333396 about?
NCT02333396 is a clinical study titled "Improving Communication in the PICU: The Navigate Study". The project seeks to study the use of an navigator-based intervention called "PICU Supports." The study will test the impact of PICU Supports during and after PICU discharge on parent outcomes (satisfaction with decision making, decision regret, anxiety, depression, post-traumatic stress, health-rel...
What is the current status of trial NCT02333396?
This trial is currently completed. It is a NA study. The enrollment target is 442 participants. The study started on 2015-04-06. Estimated completion is 2017-04-28.
What conditions does trial NCT02333396 study?
This clinical trial studies the following conditions: Communication.
What interventions are being tested in trial NCT02333396?
The interventions under investigation include: PICU Supports (OTHER), Educational Brochure (OTHER).
Who is sponsoring clinical trial NCT02333396?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02333396 being conducted?
This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Communication
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02333396's enrollment target sits among peer trials
442 16th of 34 higher than 19 of 34 other Communication trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Communication trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Seminar in Unwavering Empowering Presence Optimized for Rehabilitation Teams
RECRUITING · NA
-
Communication Strategies to Increase HPV Vaccination Intention
RECRUITING · NA
-
Multicenter HomeVENT: Home Values and Experiences Navigation Track
RECRUITING · NA
-
Alcohol and Sexual Communication Among Couples in the Laboratory
RECRUITING · NA
-
Families of Youth with Developmental Disabilities: a Theory-Based Intervention
RECRUITING · NA
-
Timing of Physician Rounds for Antepartum Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704766 · 442 participants · NA
Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis
- NCT04657068 · 442 participants · Phase 1
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- NCT05410145 · 442 participants · Phase 1
A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
- NCT06659029 · 442 participants
Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI